CONMED (CNMD) PT Raised to $129 at Needham & Company
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.26 +0.02%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Needham & Company analyst Mike Matson raised the price target on CONMED (NYSE: CNMD) to $129.00 (from $119.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $42 at Mizuho
- Clean Energy Fuels (CLNE) PT Lowered to $2.50 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
